Claire RICHARDS · Prevention of Future Deaths report

Pin Get email alerts Request correction

Issued 23 Nov 2020•County Durham and Darlington

Published report and response evidence

This report’s concerns and statements found in recipients’ published responses. Statements are included even where no link to an individual concern is recorded. A link shows an evidence connection; it does not assign responsibility.

View original report
Concerns
2

Raised in this report

Recipients
2

Named on the report

Responses found
1

Of 2 recipients

Stated actions
0

Described in responses

Recipients and published responses

Full report text

This is the full text from the original published report.

Open published report

Concerns and recipient responses

Select any concern, action or position to view the source wording.

Concerns raised2

  1. Availability of prescription drugs in vast quantities for illegal dealing to vulnerable people
    Part of recurring concern: Medication quantity controls failing to prevent unsafe access to excessive amounts
  2. Failure to prevent prescription medication leakage from the lawful dispensing process into criminal hands
    Part of recurring concern: Failure to secure and control medication

Respondent positions A position is what a recipient says about a concern when it does not describe a specific action.1

  1. Royal Pharmaceutical Society

    PHE and ACMD are the appropriate bodies to address concerns about prescription-drug misuse and medicine availability.

    Redirects responsibilityThe respondent said that another organisation was responsible for deciding or taking action.

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Availability of prescription drugs in vast quantities for illegal dealing to vulnerable people

Wider context from the report

“(1) This case involves a death resulting from illegally dealt prescription drugs. It is of increasing concern that prescription drugs are available in vast quantities for illegal dealing to vulnerable people. ”

Is this part of a recurring concern?

Yes — Medication quantity controls failing to prevent unsafe access to excessive amounts.

Open source report

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Failure to prevent prescription medication leakage from the lawful dispensing process into criminal hands

Wider context from the report

“(1) This case involves a death resulting from illegally dealt prescription drugs. It is of increasing concern that prescription drugs are available in vast quantities for illegal dealing to vulnerable people. (2) What steps are projected, or are actually in the pipe line, for stemming the leakage of prescription medication out of the lawful dispensing process into criminal hands? ”

Is this part of a recurring concern?

Yes — Failure to secure and control medication.

Open source report

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

PHE and ACMD are the appropriate bodies to address concerns about prescription-drug misuse and medicine availability.

Verbatim wording from the response

“The report outlined matters of concern including the availability of prescription medicines to vulnerable people illegally, or outside of the healthcare system and controls on availability. For this reason we believe it would be appropriate for Public Health England (PHE) and the Advisory Council for the Misuse of Drugs (ACMD), who both have roles around the misuse of drugs to be aware of this report.”

Source location

2020-0253-Response-from-Royal-Pharmaceutical-Society-Redacted.pdf
Page 1 · response
Published 29 December 2020

Open published response
Back to top

Information checked against the published report and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations

Data last updated 7 September 2026